Features | p-p38+ (n = 24), n (%) | p-p38- (n = 56), n (%) | p38+ (n = 66), n (%) | p38- (n = 14), n (%) | p |
---|---|---|---|---|---|
Sex: | |||||
Male | 16 (64) | 29 (52) | 40 (61) | 6 (42) | 1.0 |
Female | 8 (36) | 27 (48) | 26 (39) | 8 (58) | |
Age: Media, range | 55, 30–65 | 60, 25–72 | 46, 20–68 | 53,15–75 | 0.74 |
Stage: | |||||
1–2 | 8 (33) | 20 (36) | 22 (33) | 6 (43) | 0.26 |
3–4 | 16 (67) | 36 (64) | 44 (67) | 8 (57) | 0.44 |
LDH: | |||||
Normal | 15 (50) | 27 (33) | 30 (39) | 12 (29) | 0.38 |
High | 9 (50) | 29 (67) | 36 (61) | 2 (71) | 0.33 |
IPI | |||||
0–2 | 19 (33) | 38 (50) | 47 (44) | 10 (43) | 0.31 |
3–5 | 5 (67) | 18 (50) | 19 (56) | 4 (57) | 0.51 |
PS > 1 | *8 (33) | *5 (9) | *17 (26) | *1 (7) | * < 0.01 |
Bcl-2 | |||||
Positive | *24 (100) | *6 (10) | 29 (45) | 7 (50) | *0.003 |
Negative | *0 (0) | *50 (90) | 37 (55) | 7(50) | *0.007 |
GC type | ‘2 (8) | *56 (100) | *44 (66) | *14 (100) | * < 0.05 |
ABC | *22 (92) | *0 (0) | *22 (34) | *0 (0) | * < 0.01 |
NF-kB | |||||
Positive | 13 (54) | 26 (46) | 26 (40) | 6 (42) | 0.82 |
Negative | 11 (46) | 30 (54) | 40 (60) | 8 (57) | 0.96 |